In vitro antiviral activities of Caesalpinia pulcherrima and its related flavonoids
(2018) PMC: ClinicalTrials.gov NCT01550432: Intravenous glutathione prevents renal oxidative stress after coronary angiography more effectively than oral N-acetylcysteine
Beacon works with a growing network of independent healthcare providers, including physicians, functional medicine practices, and dietitians
ELI LILLY'S ORAL GLP-1 THERAPY FOUNDAYO (ORFORGLIPRON) IS NOW AVAILABLE FOR WEIGHT LOSS Foundayo is the second oral GLP-1 drug approved for weight management Straight Healthcare April 2026 April 2026 The FDA recently approved Foundayo (orforglipron), an oral glucagon-like peptide-1 (GLP-1) receptor agonist, for chronic weight management in adults
It costs $199 per month, not including the cost of medications, and features GLP-1 prescriptions and one-on-one biweekly coaching sessions
Gillingham M, Elizondo G, Behrend AM, Matern D, Schoeller DA, Harding CO, et al